| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bausch & Lomb Corp | Officer | Common Shares, No Par Value | 146,677 | $2,502,310 | $17.06 | 01 Mar 2023 | Direct |
| Bausch & Lomb Corp | Officer | Non-Qualified Stock Options (right to purchase) | 90,744 | $1,629,762 | $17.96 | 01 Mar 2023 | Direct |
| Bausch Health Companies Inc. | EVP AND GENERAL COUNSEL | Common Shares, No Par Value | 162,240 | $1,301,165 | $8.02 | 10 Mar 2022 | Direct |
| CalciMedica, Inc. | Director | Common Stock | 1,429 | $5,290 | $3.70 | 23 Mar 2023 | Direct |
| Verona Pharma plc | Director | Ordinary Shares | 0 | $0 | $106.71 | 07 Oct 2025 | Direct |
| Verona Pharma plc | Director | Restricted Share Units | 96,000 | 25 Apr 2025 | Direct | ||
| Verona Pharma plc | Director | Restricted Stock Units | 72,000 | 01 Aug 2025 | Direct | ||
| GRAYBUG VISION, INC. | Director | Stock Option (Right to Buy) | 20,000 | 02 Jun 2022 | Direct | ||
| Bausch Health Companies Inc. | EVP AND GENERAL COUNSEL | Non-Qualified Stock Options (right to purchase) | 0 | $32.03 | 02 Jun 2021 | Direct | |
| Bausch Health Companies Inc. | EVP AND GENERAL COUNSEL | Restricted Share Units | 0 | $9.40 | 27 Feb 2022 | Direct | |
| CalciMedica, Inc. | Director | Restricted Stock Unit | 0 | 23 Mar 2023 | Direct | ||
| Verona Pharma plc | Director | Restricted Share Unit | 0 | 07 Oct 2025 | Direct | ||
| Verona Pharma plc | Director | Share Options (Right to Buy) | 0 | 07 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VRNA | Verona Pharma plc | 07 Oct 2025 | 6 | $0 | 4 | Director | 08 Oct 2025, 16:30 |
| VRNA | Verona Pharma plc | 01 Aug 2025 | 3 | -$23,764 | 4 | Director | 05 Aug 2025, 20:26 |
| VRNA | Verona Pharma plc | 14 May 2025 | 3 | -$260,248 | 4 | Director | 16 May 2025, 16:30 |
| VRNA | Verona Pharma plc | 25 Apr 2025 | 1 | $0 | 4 | Director | 29 Apr 2025, 17:08 |
| VRNA | Verona Pharma plc | 06 Nov 2024 | 1 | +$198,386 | 4 | Director | 07 Nov 2024, 18:56 |
| VRNA | Verona Pharma plc | 29 Apr 2024 | 1 | $0 | 4 | Director | 30 Apr 2024, 16:17 |
| VRNA | Verona Pharma plc | 01 Sep 2023 | 1 | $0 | 4 | Director | 05 Sep 2023, 17:05 |
| VRNA | Verona Pharma plc | 01 Sep 2023 | 0 | $0 | 3 | Director | 05 Sep 2023, 17:05 |
| CALC | CalciMedica, Inc. | 23 Mar 2023 | 2 | $0 | 4 | Director | 27 Mar 2023, 19:54 |
| BLCO | Bausch & Lomb Corp | 01 Mar 2023 | 2 | +$1,629,762 | 4 | Officer | 03 Mar 2023, 15:55 |
| BLCO | Bausch & Lomb Corp | 25 Jul 2022 | 1 | $0 | 4 | Officer | 27 Jul 2022, 19:38 |
| CALC | GRAYBUG VISION, INC. | 02 Jun 2022 | 2 | $0 | 4 | Director | 03 Jun 2022, 17:31 |
| BLCO | Bausch & Lomb Corp | 05 May 2022 | 2 | $0 | 4 | Officer | 09 May 2022, 18:46 |
| BLCO | Bausch & Lomb Corp | 05 May 2022 | 0 | $0 | 3 | Officer | 05 May 2022, 18:33 |
| BHC | Bausch Health Companies Inc. | 10 Mar 2022 | 1 | -$18,928 | 4 | EVP AND GENERAL COUNSEL | 11 Mar 2022, 15:00 |
| BHC | Bausch Health Companies Inc. | 03 Mar 2022 | 1 | -$163,523 | 4 | EVP AND GENERAL COUNSEL | 07 Mar 2022, 16:45 |
| BHC | Bausch Health Companies Inc. | 26 Feb 2022 | 6 | -$981,792 | 4 | EVP AND GENERAL COUNSEL | 02 Mar 2022, 20:06 |
| BHC | Bausch Health Companies Inc. | 27 Aug 2021 | 1 | -$145,242 | 4 | EVP AND GENERAL COUNSEL | 31 Aug 2021, 16:07 |
| CALC | GRAYBUG VISION, INC. | 02 Jun 2021 | 1 | $0 | 4 | Director | 04 Jun 2021, 18:30 |
| BHC | Bausch Health Companies Inc. | 02 Jun 2021 | 5 | -$2,057,703 | 4 | EVP AND GENERAL COUNSEL | 04 Jun 2021, 16:51 |